Boothbay Fund Management »

Monte Rosa Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $163k 35k 4.64
2024-12-31 $633k 91k 6.94
2024-09-30 $484k 91k 5.30

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics